Quick Answer
GLP-1 drugs like Ozempic cause muscle loss alongside fat loss. A 2026 Stanford study found a compound (MF-300) that helps preserve muscle during semaglutide treatment — and Indian patients can act now.
Free Consultation
Have questions about GLP-1 Therapy?
Enter your phone number — a specialist calls you back in 30 minutes. Free, no commitment.
🔒 Confidential · No spam · 10,000+ patients helped
One of the most common concerns among Indian patients taking GLP-1 medications like Ozempic (semaglutide) or Mounjaro (tirzepatide) is muscle loss. When you lose weight rapidly, your body does not just burn fat — it also loses some muscle along the way. A new study from Stanford University, published in June 2026 in the Proceedings of the National Academy of Sciences, has identified a promising compound that may help GLP-1 users preserve and repair muscle while still losing fat effectively.
What Did the Stanford Study Find?
Stanford Medicine researchers tested an experimental compound called MF-300 — a PGDH inhibitor — alongside semaglutide in animal models. The results were encouraging: subjects treated with both semaglutide and MF-300 showed significantly enhanced muscle repair after injury, without any reduction in fat loss. In other words, the drug allowed the body to lose fat while simultaneously recovering muscle that had been damaged or wasted. The researchers believe the same approach could eventually work in humans on GLP-1 medications.
MF-300 has already completed Phase 1 clinical trials in humans, where it was confirmed safe. Phase 2b trials for age-related muscle loss (sarcopenia) are planned for later in 2026. The Stanford team hopes that a PGDH inhibitor like MF-300 could become a standard companion drug to GLP-1 therapy — so patients lose fat without sacrificing muscle strength.
Why Does Muscle Loss Matter During GLP-1 Treatment?
When you lose weight with GLP-1 drugs, the scale goes down — but a portion of that weight loss comes from muscle, not just fat. Unlike fat, muscle does not come back quickly once it is lost. Muscle loss during weight reduction can cause persistent weakness and fatigue, difficulty with everyday activities like climbing stairs or carrying groceries, a slower metabolism that makes it harder to maintain weight loss long term, and increased risk of falls and injury in older patients.
Free Consultation
Have questions about GLP-1 Therapy?
Enter your phone number — a specialist calls you back in 30 minutes. Free, no commitment.
🔒 Confidential · No spam · 10,000+ patients helped
For Indian patients — many of whom start GLP-1 therapy while already dealing with some degree of diabetes-related or age-related muscle weakness — this is a real and growing medical concern. Endocrinologists across India are seeing this in clinical practice and taking it increasingly seriously.
What Indian Patients Should Know Right Now
MF-300 is not yet available as an approved medication. It is still in clinical trials and likely 2 to 3 years away from widespread use. However, this research matters for two important reasons. First, it confirms that muscle preservation during GLP-1 therapy is a legitimate medical concern, not just a worry for fitness enthusiasts. Second, it points toward a near future where GLP-1 drugs will have companion therapies designed to prevent this side effect from the start.
In the meantime, Indian patients currently on GLP-1 medications can take several evidence-based steps to protect their muscle. Prioritise protein in every meal — aim for at least 1.2 grams of protein per kilogram of body weight each day. Indian foods like dal, paneer, eggs, chicken, and thick curd are excellent options and easy to include in a daily diet. Add resistance training to your routine — even 2 to 3 sessions per week of simple bodyweight exercises, squats, push-ups, and lunges, or light free weights can significantly reduce muscle loss during rapid weight reduction. Work with a specialist, not just a general physician — a doctor experienced in GLP-1 therapy will monitor your body composition rather than just your total weight on the scale, ensuring you are primarily losing fat rather than muscle.
Are GLP-1 Drugs Still Worth Taking Despite This Risk?
Absolutely — and most experts firmly agree. The benefits of GLP-1 therapy for Indian patients are substantial: 10 to 15 percent total body weight reduction, dramatically improved blood sugar control in type 2 diabetes, reduced cardiovascular risk, and, as recent research suggests, potentially lower cancer risk. The risk of moderate muscle loss is real but manageable with the right guidance. The key is not avoiding GLP-1 therapy — it is managing it correctly from the start, with expert supervision and a personalised plan.
Free Consultation
Have questions about GLP-1 Therapy?
Enter your phone number — a specialist calls you back in 30 minutes. Free, no commitment.
🔒 Confidential · No spam · 10,000+ patients helped
Access to GLP-1 therapy in India has also improved significantly. With generic semaglutide now available from Indian pharmaceutical companies, monthly costs start at around Rs 4,000 — a fraction of what branded Ozempic used to cost. This means more Indian patients can now start treatment under proper medical supervision.
How MySurgery Can Help
MySurgery connects Indian patients with experienced GLP-1 specialists across Delhi, Mumbai, Bangalore, Chennai, Hyderabad, and Pune. Our specialists monitor full body composition during treatment and provide personalised advice on nutrition and exercise to protect your muscle while you lose fat. We also help you access the most cost-effective generic options available in your city.
Call MySurgery at 8588967050 or WhatsApp us to speak with a GLP-1 specialist. Free consultation, callback in 30 minutes.
MySurgery GLP-1 Team
GLP-1 Research & Patient Education
Have questions about GLP-1 Therapy?
Free consultation. Expert doctors. Callback in 30 minutes.